NPI: 1518449784 · ASHBURN, VA 20147 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/04/2018
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 09/04/2018 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 4,426 | $73K |
| 2020 | 9,368 | $117K |
| 2022 | 95 | $17K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 3,457 | 208 | $180K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 95 | 13 | $17K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 4,776 | 177 | $8K |
| J1756 | Injection, iron sucrose, 1 mg | 203 | 39 | $1K |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,436 | 227 | $372.39 |
| 83970 | 181 | 104 | $230.28 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 108 | 35 | $207.81 |
| 82728 | 155 | 98 | $45.76 | |
| 83550 | 187 | 114 | $39.44 | |
| 82607 | 54 | 30 | $33.50 | |
| 82746 | 54 | 30 | $32.68 | |
| 83540 | 187 | 114 | $29.21 | |
| A4657 | Syringe, with or without needle, each | 452 | 191 | $20.87 |
| 85041 | 272 | 169 | $17.03 | |
| 85048 | 272 | 169 | $14.36 |